Director/PDMR Shareholding
Updated : 11:26
Spectris plc: Director/PDMR Shareholding
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
On 1 March 2019, Spectris plc ("the Company") was notified by Derek Harding, Chief Financial Officer Designate, that his spouse had today acquired 4,000 ordinary shares at a price of 2,657.94 pence per share.
The form required under the EU Market Abuse Regulation follows.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Derek Harding | |
2 | Reason for the notification | ||
a) | Position/status | Director | |
b) | Initial notification/Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Spectris plc | |
b) | LEI | 213800Z4CO2CZO3M3T10 | |
4 | Details of the transaction(s): section to be repeated for (i) e ach type of instrument; (ii) each type of transaction; (iii) each date ; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 5p each
| |
b) | Nature of the transaction | Spectris plc received notification on 1 March 2019 that Fiona Harding, spouse of Derek Harding, had purchased 4,000 ordinary shares of 5p each in Spectris plc on 1 March 2019, to be held in a nominee account on her behalf. | |
c) | Price(s) and volume(s) | Price | Volume(s) |
£26.5794 | 4,000 | ||
d) | Aggregated information | Aggregated Volume | 4,000 |
Price | £26.5794 | ||
e) | Date of the transaction | 1 March 2019 | |
f) | Place of the transaction | London Stock Exchange: LON |
Name of contact and telephone number for queries:
Rebecca Dunn
Deputy Company Secretary
01784 470 470
For and on behalf of Spectris plc
Date: 1 March 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.